非清髓性异基因造血干细胞移植治疗非霍奇金淋巴瘤：第54届美国血液学会年会报道  

Non-myeloablative allogeneic hematopoietic stem cell transplantation in the treatment of non-Hodgkin＇s lymphoma： the 54th ASH annual meeting

作　　者：刘小兰[1] 苏丽萍[1] 

机构地区：[1]山西省肿瘤医院血液科,太原030013

出　　处：《白血病．淋巴瘤》2012年第12期709-711,715,共4页Journal of Leukemia & Lymphoma

摘　　要：在第54届美国血液学会（ASH）年会上，与造血干细胞移植相关的报道共417篇，其中46篇与淋巴瘤相关。对年会有关非清髓性异基因造血干细胞移植治疗非霍奇金淋巴瘤方面的报道进行介绍。There were 417 scientific articles on hematopoietic stem cell transplantation in the 54th annual meeting of American Society of Hematology （ASH）, including 46 articles on lymphoma. This article reviews latest research on non-myeloablative allogeneic hematopoietic stem cell transplantation for the treatment non-Hodgkin＇s lymphoma presented in the meeting.

关 键 词：淋巴瘤 非霍奇金 非清髓性异基因造血干细胞移植 美国血液学会年会 

分 类 号：R733.1[医药卫生—肿瘤]